SLC25A5 and breast cancer: Owing to the unique feature of overt ANT2 overexpression in breast cancer and ovarian cancer cell lines, we hypothesized that the downregulation of ANT2 in these cell lines may induce serious physiological effects that result in cell growth inhibition or cell death.